Literature DB >> 2877335

No evidence for increased risk of Lassa fever infection in hospital staff.

C G Helmick, P A Webb, C L Scribner, J W Krebs, J B McCormick.   

Abstract

A prospective serological study was undertaken in hospital personnel who care for Lassa fever (LF) patients in an endemic region of Sierra Leone, West Africa. Among personnel from three hospitals where barrier nursing is practised, antibody prevalence and seroconversion by age and sex were consistently equal to or lower than those of persons in nearby village populations. No group among hospital personnel evaluated by age, sex, contact, or occupational exposure was at higher risk than another. Hospital staff in Sierra Leone who care for LF patients using simple barrier nursing methods have no higher risk of infection than the local population. These findings support the proposal that patients with LF in non-endemic countries need not be confined to isolators.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2877335     DOI： 10.1016/s0140-6736(86)92206-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  16 in total

1.  Lassa fever - full recovery without ribavarin treatment: a case report.

Authors:  Nnennaya A Ajayi; Kingsley N Ukwaja; Ngozi A Ifebunandu; Richard Nnabu; Francis I Onwe; Danny A Asogun
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  "Life in a germ-free world": isolating life from the laboratory animal to the bubble boy.

Authors:  Robert G Kirk
Journal:  Bull Hist Med       Date:  2012       Impact factor: 1.314

3.  A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.

Authors:  M E Price; S P Fisher-Hoch; R B Craven; J B McCormick
Journal:  BMJ       Date:  1988-09-03

4.  Safe IV opioid titration in patients with severe acute pain.

Authors:  Chris Pasero
Journal:  J Perianesth Nurs       Date:  2010-10       Impact factor: 1.084

5.  Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.

Authors:  George F Risi; Marshall E Bloom; Nancy P Hoe; Thomas Arminio; Paul Carlson; Tamara Powers; Heinz Feldmann; Deborah Wilson
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

Review 6.  Mapping the zoonotic niche of Lassa fever in Africa.

Authors:  Adrian Q N Mylne; David M Pigott; Joshua Longbottom; Freya Shearer; Kirsten A Duda; Jane P Messina; Daniel J Weiss; Catherine L Moyes; Nick Golding; Simon I Hay
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-06-17       Impact factor: 2.184

7.  Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever.

Authors:  Giovanni Lo Iacono; Andrew A Cunningham; Elisabeth Fichet-Calvet; Robert F Garry; Donald S Grant; Sheik Humarr Khan; Melissa Leach; Lina M Moses; John S Schieffelin; Jeffrey G Shaffer; Colleen T Webb; James L N Wood
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

8.  Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit.

Authors:  Anna Grahn; Andreas Bråve; Martin Lagging; Leif Dotevall; David Ekqvist; Helena Hammarström; Helen Karlberg; Nina Lagerqvist; Martina Sansone; Anders Tegnell; Peter Ulleryd; Marie Studahl
Journal:  Open Forum Infect Dis       Date:  2016-09-20       Impact factor: 3.835

Review 9.  Pathogenesis of Lassa fever.

Authors:  Nadezhda E Yun; David H Walker
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048

Review 10.  Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review.

Authors:  Mona Hersi; Adrienne Stevens; Pauline Quach; Candyce Hamel; Kednapa Thavorn; Chantelle Garritty; Becky Skidmore; Constanza Vallenas; Susan L Norris; Matthias Egger; Sergey Eremin; Mauricio Ferri; Nahoko Shindo; David Moher
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.